Compared to other patients suffering from hematological malignancies, classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) patients have a long life expectancy when in complete remission at the end of first, or sometimes second, line treatments [...].
Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma / Bari, A., Gerardi, C., Allocati, E., Puzzovivo, A., De Sanctis, V., Tucci, A., Balzarotti, M., Franceschetti, S., Merli, F., Guarini, A., Gini, G., Minoia, C.. - In: CANCERS. - ISSN 2072-6694. - 14:23(2022), pp. 1-5. [10.3390/cancers14235960]
Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma
De Sanctis V.;
2022
Abstract
Compared to other patients suffering from hematological malignancies, classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) patients have a long life expectancy when in complete remission at the end of first, or sometimes second, line treatments [...].File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Bari_Clinical-Management-ofLong-Term-Survivors_2022.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
200.23 kB
Formato
Adobe PDF
|
200.23 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
